296.00 0.00 (0.00%)
After hours: 4:25PM EST
|Bid||296.01 x 1000|
|Ask||296.22 x 1100|
|Day's Range||281.38 - 297.71|
|52 Week Range||107.44 - 297.71|
|Beta (5Y Monthly)||0.82|
|PE Ratio (TTM)||269.09|
|Earnings Date||Apr 28, 2020 - May 03, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||292.60|
Dexcom stock rocketed to a record high Friday after the diabetes treatment outlet topped its pre-announced fourth-quarter revenue by $6 million. Analysts are bullish on the stock.
The major stock indexes were mixed early Friday after U.S. retail sales. Nvidia, Roku and Dexcom soared on earnings results.
Several Dexcom analysts raised their share-price targets for the diabetes-treatment company after its fourth-quarter earnings beat Wall Street's estimates.
Dow Jones futures rose modestly early Friday, along with S&P 500 futures and Nasdaq futures, after the stock market rally held its ground Thursday. Nvidia, Dexcom, Roku, Datadog and Alteryx reported earnings after the close.
Dexcom stock popped Thursday after the diabetes treatment outlet crushed Wall Street's fourth-quarter earnings forecasts. The company also offered better-than-expected sales guidance.
The Zacks Analyst Blog Highlights: Waste Management, TC Energy, Duke Energy, DexCom and Republic Services
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 12) AbbVie Inc (NYSE: ABBV ) Agile Therapeutics Inc (NASDAQ: ...
Although corporate earnings growth was negative year over year in the first three quarters of last year, fourth-quarter results have been faring better than initially anticipated.
Futures fell on virus fears, with Apple iPhone, Tesla China plants in focus: The market rally has been surprising, but isn't "different this time." Alibaba, Nvidia, Shopify, Dexcom earnings loom.
Diabetes-related stocks remain a strong theme, and Dexcom (DXCM) is our top pick in the group, explains Mike Cintolo, editor of Cabot Growth Investor.
DexCom (DXCM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.